ACKR4 on stromal cells scavenges CCL19 to enable CCR7-dependent trafficking of APCs from inflamed skin to lymph nodes

Journal of Immunology

Volumn 196, Issue 8, 2016, Pages 3341-3353

  Bryce, Steven A ^a   Wilson, Ruairi A M ^a   Tiplady, Eleanor M ^a   Asquith, Darren L ^a   Bromley, Shannon K ^b   Luster, Andrew D ^b   Graham, Gerard J ^a   Nibbs, Robert J B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACKR4 PROTEIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; CCL19 PROTEIN, MOUSE; CCR7 PROTEIN, MOUSE; CCRL1 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CCL19 GENE; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; DERMATITIS; ENDOTHELIUM CELL; GENE DELETION; INFLAMMATION; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; STROMA CELL; ANIMAL; C57BL MOUSE; CELL MOTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; SKIN;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL19; CHEMOKINE CCL21; DENDRITIC CELLS; ENDOTHELIAL CELLS; INFLAMMATION; KERATINOCYTES; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN TRANSPORT; RECEPTORS, CCR; RECEPTORS, CCR7; SKIN; STROMAL CELLS;

EID: 84974782361     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501542     Document Type: Article

References (42)

1. Merad, M., F. Ginhoux, and M. Collin. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8: 935-947.
2. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371.
3. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T. Blankenstein, G. Henning, and R. Förster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288.
4. Weber, M., R. Hauschild, J. Schwarz, C. Moussion, I. de Vries, D. F. Legler, S. A. Luther, T. Bollenbach, and M. Sixt. 2013. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339: 328-332.
5. Braun, A., T. Worbs, G. L. Moschovakis, S. Halle, K. Hoffmann, J. Bölter, A. Münk, and R. Förster. 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12: 879-887.
6. Pflicke, H., and M. Sixt. 2009. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 206: 2925-2935.
7. Förster, R., A. Braun, and T. Worbs. 2012. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol. 33: 271-280.
8. Tal, O., H. Y. Lim, I. Gurevich, I. Milo, Z. Shipony, L. G. Ng, V. Angeli, and G. Shakhar. 2011. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208: 2141-2153.
9. Wendland, M., S.Willenzon, J. Kocks, A. C. Davalos-Misslitz, S. I. Hammerschmidt, K. Schumann, E. Kremmer, M. Sixt, A. Hoffmeyer, O. Pabst, and R. Förster. 2011. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35: 945-957.
10. Moussion, C., and J.-P. Girard. 2011. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479: 542-546.
11. Link, A., T. K. Vogt, S. Favre, M. R. Britschgi, H. Acha-Orbea, B. Hinz, J. G. Cyster, and S. A. Luther. 2007. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8: 1255-1265.
12. Britschgi, M. R., S. Favre, and S. A. Luther. 2010. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur. J. Immunol. 40: 1266-1271.
13. de Paz, J. L., E. A. Moseman, C. Noti, L. Polito, U. H. von Andrian, and P. H. Seeberger. 2007. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2: 735-744.
14. Hirose, J., H. Kawashima, M. Swope Willis, T. A. Springer, H. Hasegawa, O. Yoshie, and M. Miyasaka. 2002. Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. Biochim. Biophys. Acta 1571: 219-224.
15. Patel, D. D., W. Koopmann, T. Imai, L. P. Whichard, O. Yoshie, and M. S. Krangel. 2001. Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99: 43-52.
16. Schumann, K., T. Lämmermann, M. Bruckner, D. F. Legler, J. Polleux, J. P. Spatz, G. Schuler, R. Förster, M. B. Lutz, L. Sorokin, and M. Sixt. 2010. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32: 703-713.
17. Nibbs, R. J. B., and G. J. Graham. 2013. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13: 815-829.
18. Bachelerie, F., A. Ben-Baruch, A. M. Burkhardt, C. Combadiere, J. M. Farber, G. J. Graham, R. Horuk, A. H. Sparre-Ulrich, M. Locati, A. D. Luster, et al. 2014. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66: 1-79.
19. Gosling, J., D. J. Dairaghi, Y. Wang, M. Hanley, D. Talbot, Z. Miao, and T. J. Schall. 2000. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell-and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164: 2851-2856.
20. Townson, J. R., and R. J. B. Nibbs. 2002. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/ mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR. Eur. J. Immunol. 32: 1230-1241.
21. Heinzel, K., C. Benz, and C. C. Bleul. 2007. A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proc. Natl. Acad. Sci. USA 104: 8421-8426.
22. Comerford, I., S. Milasta, V. Morrow, G. Milligan, and R. Nibbs. 2006. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur. J. Immunol. 36: 1904-1916.
23. Ulvmar, M. H., K. Werth, A. Braun, P. Kelay, E. Hub, K. Eller, L. Chan, B. Lucas, I. Novitzky-Basso, K. Nakamura, et al. 2014. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15: 623-630.
24. Ribeiro, A. R., C. Meireles, P. M. Rodrigues, and N. L. Alves. 2014. Intermediate expression of CCRL1 reveals novel subpopulations of medullary thymic epithelial cells that emerge in the postnatal thymus. Eur. J. Immunol. 44: 2918-2924.
25. Bunting, M. D., I. Comerford, N. Seach, M. V. Hammett, D. L. Asquith, H. Körner, R. L. Boyd, R. J. B. Nibbs, and S. R. McColl. 2013. CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity. Blood 121: 118-128.
26. Comerford, I., R. J. Nibbs, W. Litchfield, M. Bunting, Y. Harata-Lee, S. Haylock-Jacobs, S. Forrow, H. Körner, and S. R. McColl. 2010. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 116: 4130-4140.
27. Tomura, M., N. Yoshida, J. Tanaka, S. Karasawa, Y. Miwa, A. Miyawaki, and O. Kanagawa. 2008. Monitoring cellular movement in vivo with photoconvertible fluorescence protein "Kaede" transgenic mice. Proc. Natl. Acad. Sci. USA 105: 10871-10876.
28. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23-33.
29. Jamieson, T., D. N. Cook, R. J. B. Nibbs, A. Rot, C. Nixon, P. McLean, A. Alcami, S. A. Lira, M. Wiekowski, and G. J. Graham. 2005. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6: 403-411.
30. Jamieson, T., M. Clarke, C. W. Steele, M. S. Samuel, J. Neumann, A. Jung, D. Huels, M. F. Olson, S. Das, R. J. B. Nibbs, and O. J. Sansom. 2012. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122: 3127-3144.
31. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189: 451-460.
32. Nakano, H., and M. D. Gunn. 2001. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J. Immunol. 166: 361-369.
33. Hansell, C. A. H., C. Schiering, R. Kinstrie, L. Ford, Y. Bordon, I. B. McInnes, C. S. Goodyear, and R. J. B. Nibbs. 2011. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117: 5413-5424.
34. Ford, L. B., V. Cerovic, S. W. F. Milling, G. J. Graham, C. A. H. Hansell, and R. J. B. Nibbs. 2014. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes. J. Immunol. 193: 400-411.
35. McKimmie, C. S., M. D. Singh, K. Hewit, O. Lopez-Franco, M. Le Brocq, S. Rose-John, K. M. Lee, A. H. Baker, R. Wheat, D. J. Blackbourn, et al. 2013. An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood 121: 3768-3777.
36. Nibbs, R. J., E. Kriehuber, P. D. Ponath, D. Parent, S. Qin, J. D. Campbell, A. Henderson, D. Kerjaschki, D. Maurer, G. J. Graham, and A. Rot. 2001. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158: 867-877.
37. Weber, M., E. Blair, C. V. Simpson, M. O'Hara, P. E. Blackburn, A. Rot, G. J. Graham, and R. J. B. Nibbs. 2004. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol. Biol. Cell 15: 2492-2508.
38. Nibbs, R. J. B., D. S. Gilchrist, V. King, A. Ferra, S. Forrow, K. D. Hunter, and G. J. Graham. 2007. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117: 1884-1892.
39. Bardi, G., M. Lipp, M. Baggiolini, and P. Loetscher. 2001. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC. Eur. J. Immunol. 31: 3291-3297.
40. Kohout, T. A., S. L. Nicholas, S. J. Perry, G. Reinhart, S. Junger, and R. S. Struthers. 2004. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 279: 23214-23222.
41. Ouwehand, K., S. J. A. M. Santegoets, D. P. Bruynzeel, R. J. Scheper, T. D. de Gruijl, and S. Gibbs. 2008. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur. J. Immunol. 38: 3050-3059.
42. Kabashima, K., N. Shiraishi, K. Sugita, T. Mori, A. Onoue, M. Kobayashi, J. Sakabe, R. Yoshiki, H. Tamamura, N. Fujii, et al. 2007. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171: 1249-1257.